Dr. Weiner reviews a recently published deep dive into ketamine's use as a rapid antidepressant, exploring its potential and pitfalls and highlighting therapeutic effects, ethical concerns, and safety issues in treatment-resistant depression.

New (May 2024) research unveils the mechanisms behind ketamine's ability to induce altered brain oscillations, offering profound insights into its therapeutic potential and the nature of consciousness itself.

A recent study explores the effect of a “relational dose” of ketamine combined with Imago relationship therapy for couples; quantitative data showed significant improvements in relationship satisfaction scores post-treatment, with benefits persisting for up to 15 months.

A recent study offers a fresh perspective on pain by applying the lens of complexity science to chronic pain. We review the study's key points and discuss how psychedelic therapies may offer promising solutions.

A recent study examined the role of the therapeutic alliance between patients and intervention facilitators in PAT for MDD. The study found that a stronger therapeutic alliance was associated with more positive outcomes for patients.